Skip to main content
    C

    CryoCell International Inc (CCEL)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • AMEX

    $4.65
    +0.00 (+0.00%)

    Market Cap: $37.49M

    Last updated: Oct 20, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    83%(20/24)
    Avg Surprise
    -5.08%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Nov 30, 2026
    EPS Consensus$0.10
    Range$0.10 - $0.10
    1 analysts
    Revenue Consensus
    $7M
    Range$7M - $7M
    1 analysts
    Period ending Feb 28, 2027
    EPS Consensus$0.02
    Range$0.02 - $0.02
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$0.00n/a
    7d ago$0.00n/a
    Current$0.02
    Revenue Consensus
    $7M
    Range$7M - $7M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Feb 27EST
    		-$0.02---
    Nov 26EST
    		-$0.10---
    Aug 26
    Reported Oct 9
    		$0.16$0.03+433.33%Beat+60.0%
    May 26
    Reported Jul 15
    		$0.07$0.00N/ABeat+40.0%
    Feb 26
    Reported Apr 14
    		$0.02$-0.02+200.00%Beat-60.0%
    Nov 25
    Reported Feb 27
    		$-0.47$-0.03-1452.00%Miss-82.9%
    Aug 25
    Reported Oct 15
    		$0.10$-0.03+433.33%Beat-28.6%
    May 25
    Reported Jul 15
    		$0.05$-0.04+225.00%Beat-50.0%
    Feb 25
    Reported Apr 14
    		$0.05$0.01+400.00%Beat-44.4%
    Nov 24
    Reported Feb 26
    		$-0.25$0.02-1372.50%Miss+81.0%
    Aug 24
    Reported Oct 15
    		$0.14$0.03+366.67%Beat+55.6%
    May 24
    Reported Jul 15
    		$0.10$0.05+100.00%Beat+400.0%
    Feb 24
    Reported Apr 15
    		$0.09$-0.01+1000.00%Beat+12.5%
    Nov 23
    Reported Feb 28
    		$-1.34$-0.07-1814.29%Miss-1440.0%
    Aug 23
    Reported Oct 12
    		$0.09$-0.05+280.00%Beat+80.0%
    May 23
    Reported Jul 14
    		$0.02N/A+128.57%Beat-75.0%
    Feb 23
    Reported Apr 21
    		$0.08$-0.03+366.67%Beat-20.0%
    Nov 22
    Reported Feb 28
    		$0.10$-0.02+600.00%Beat+242.9%
    Aug 22
    Reported Oct 14
    		$0.05$0.06-16.67%Miss-50.0%
    May 22
    Reported Jul 11
    		$0.08$0.08+0.00%Beat-42.9%
    Feb 22
    Reported Apr 13
    		$0.10N/AN/ABeat+25.0%
    Nov 21
    Reported Feb 22
    		$-0.07N/AN/ABeat-146.7%
    Aug 21
    Reported Oct 15
    		$0.10N/AN/ABeat+0.0%
    May 21
    Reported Jul 15
    		$0.14$0.14+0.00%Beat+16.7%
    Feb 21
    Reported Apr 14
    		$0.08$0.08+0.00%Beat+0.0%
    Nov 20
    Reported Feb 24
    		$0.15$0.15+0.00%Beat+117.4%
    Aug 20
    Reported Oct 15
    		$0.10$0.10+0.00%Beat-23.1%
    May 20
    Reported Jul 10
    		$0.12$0.12+0.00%Beat+1100.0%
    Feb 20
    Reported Apr 14
    		$0.08$0.08+0.00%Beat+166.7%
    Nov 19
    Reported Feb 27
    		$-0.86N/AN/ABeat-761.5%
    Aug 19
    Reported Oct 15
    		$0.13$0.13+0.00%Beat+333.3%
    May 19
    Reported Jul 15
    		$0.01N/AN/ABeat-85.7%
    Feb 19
    Reported Apr 15
    		$0.03N/AN/ABeat+109.1%
    Nov 18
    Reported Feb 28
    		$0.13$0.00N/ABeat-72.9%
    Aug 18
    Reported Oct 15
    		$0.03N/AN/ABeat-62.5%
    May 18
    Reported Jul 16
    		$0.07N/AN/ABeat+16.7%
    Feb 18
    Reported Apr 16
    		$-0.33N/AN/ABeat-571.4%
    Nov 17
    Reported Feb 28
    		$0.48$0.00N/ABeat+585.7%
    Aug 17
    Reported Oct 16
    		$0.08N/AN/ABeat-
    May 17
    Reported Jul 7
    		$0.06N/AN/ABeat-
    Feb 17
    Reported Apr 14
    		$0.07N/AN/ABeat-
    Nov 16
    Reported Feb 28
    		$0.07$0.00N/ABeat-

    Dividends

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00
    Payout Ratio0.00%
    FrequencyQuarterly

    Key Metrics

    Valuation
    P/E Ratio-21.57EV/EBITDA35.13x
    Price/FCF8.06xFCF Yield12.41%
    Profitability
    Profit Margin-6.25%Operating Margin28.00%
    ROE129.20%ROIC1.15%
    Financial Health
    Debt/Equity-0.56xInterest Coverage2.50x
    Current Ratio0.86xQuick Ratio0.82x
    Trading Statistics
    Beta0.59Avg Volume12.95K
    52-Week High$4.9052-Week Low$2.72

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.28
    SMA 20$4.15
    SMA 50$4.15
    SMA 200$3.62
    EMA 10$4.31
    EMA 20$4.22
    EMA 50$4.08
    EMA 200$3.89

    MACD

    Line: 0.09Signal: 0.04Hist: 0.05

    ADX

    ADX: 15.1+DI: 23.0-DI: 21.8

    Aroon & PSAR

    Aroon Up76.0
    Aroon Down60.0
    PSAR$3.75

    Bollinger Bands

    Upper Band$4.70
    Lower Band$3.60
    %B Position2645%(Upper)
    Band Width0.95

    RSI (14-Day)

    Neutral
    58.2

    Momentum Oscillators

    Stoch %K78.5
    Stoch %D59.6
    Williams %R-16.3
    ROC (10d)19.8%
    Momentum0.77
    CCI (20d)175.5
    MFI (14d)58.2

    Volatility Measures

    ATR (14d)$0.42(9.1%)
    StdDev (20d)0.27
    Hist Vol107.3%(High)

    Volume Flow

    VWAP$4.67
    OBV1.1M
    AD Line-532.1K
    CMF (20d)-0.236

    Volume Metrics

    Avg Vol (20d)12.2K
    Vol Ratio0.6x
    VWMA (20d)$4.18

    Pivot Points

    R3$5.31
    R2$5.05
    R1$4.85
    Pivot Point$4.60
    S1$4.40
    S2$4.14
    S3$3.94

    Advanced Oscillators

    TSI6.56
    Ultimate Osc44.7
    KST18.23

    Financial Data

    QuarterAug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024Aug 2024May 2024Feb 2024Nov 2023
    Total Revenue$7.82M$7.78M$7.68M$7.84M$7.83M$7.93M$7.97M$8.02M$8.07M$8.04M$7.85M$7.88M
    Cost of Revenue$1.61M$1.68M$1.66M$1.73M$1.80M$1.86M$1.98M$1.73M$2.13M$2.02M$2.07M$2.02M
    Gross Profit$6.21M$6.10M$6.03M$6.11M$6.02M$6.07M$5.98M$6.29M$5.94M$6.02M$5.79M$5.85M
    Operating Expenses$4.02M$4.90M$5.26M$10.08M$4.12M$4.58M$4.93M$6.42M$4.55M$4.63M$4.96M$22.03M
    R&D$53,624$99,781$65,761$84,784$61,625$131,711$98,143$304,629$193,933$241,085$502,889$443,808
    SG&A$3.78M$4.62M$5.01M$5.45M$3.88M$4.26M$4.64M$5.92M$4.16M$4.02M$4.43M$5.44M
    Operating Income$2.19M$1.20M$765,134$-3,966,787$1.90M$1.49M$1.06M$-122,347$1.39M$1.39M$821,223$-16,176,145
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$438,305$441,917$462,709$481,949$538,219$551,126$494,962$745,488$533,464$329,273$256,459$-169,031
    Income Before Tax$1.83M$827,781$70,309$-4,631,970$1.19M$575,103$533,718$-842,434$1.38M$1.47M$794,510$-15,993,058
    Income Tax Expense$554,958$273,195$23,201$-814,537$436,588$219,318$250,863$1.02M$328,186$816,390$238,269$-4,803,040
    Net Income$1.27M$554,586$47,108$-3,817,433$749,408$355,785$282,855$-1,861,615$1.05M$655,790$556,241$-11,190,018
    EBITDA$2.60M$1.62M$880,153$-3,814,623$2.08M$1.48M$1.37M$247,772$2.25M$2.00M$1.22M$-15,746,807
    EBIT$2.26M$1.27M$533,018$-4,150,021$1.72M$1.13M$1.03M$-96,946$1.91M$1.80M$1.05M$-16,162,089
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CCEL

    News

    Four director nominees face a shareholder vote at Cryo-Cell (CCEL) on October 27, 2026.

    Cryo-Cell International, Inc. (CCEL) will hold its annual meeting on October 27, 2026, where shareholders will vote on four director nominees, the ratification of Wipfli LLP as independent auditors...

    Stock Titan•10/13/26•Neutral

    Cryo-Cell International, Inc. (CCEL) Tops Q3 EPS by 13c

    Cryo-Cell International, Inc. (CCEL) reported Q3 EPS of $0.16, significantly exceeding the analyst estimate of $0.03 by $0.13. The company's revenue for the quarter also surpassed expectations...

    StreetInsider•10/12/26•Bullish

    Goodyear Tire, Cryo-Cell International And 3 Stocks To Watch Heading Into Monday

    This article highlights five stocks to watch on Monday, October 12, 2026, as U.S. stock futures trade higher. Goodyear Tire & Rubber Co. appointed a new chairman, Pomdoctor Ltd. faces Nasdaq delisting...

    Benzinga•10/12/26•Somewhat-Bullish

    Cryo-Cell International Q3 2026 Earnings Results and Report

    Cryo-Cell International (CCEL) announced its Q3 2026 earnings on October 9, 2026, reporting an EPS of $0.16 and revenue of $7.82 million. The company's stock closed at $4.36, up 4.56%, on October 9...

    MarketBeat•10/10/26•Somewhat-Bullish

    Cryo-Cell Q3FY26 Results: Net income rises 70% to $1.27 million

    Cryo-Cell International reported a significant 69.6% increase in net income to $1.27 million for Q3FY26, up from $749,000 in the prior year...

    scanx.trade•10/9/26•Bullish

    CCEL Valuation and Fair Value

    P/E
    -21.6x
    Forward P/E
    2000.0x
    EV/EBITDA
    35.1x
    P/FCF
    8.1x
    PEG
    1.3x
    P/B
    -2.3x
    See GNG's fair value

    CCEL Profitability: Margins, ROIC and FCF

    Gross margin
    78.5%
    Operating margin
    28.0%
    Net margin
    -6.3%
    ROIC
    1.1%
    ROE
    129.2%
    FCF margin
    14.9%
    FCF yield
    12.4%

    CCEL Competitors

    CompanyTicker
    Edesa Biotech IncEDSA
    eXoZymes, Inc.EXOZ
    Precipio IncPRPO
    Harvard Bioscience IncHBIO
    Rapid Micro Biosystems IncRPID
    Star Equity Holdings IncSTRR
    Veru IncVERU
    Scynexis IncSCYX

    Sector: Healthcare

    CCEL Bull Case vs Bear Case

    Bull case

    • CCEL beat EPS estimates in 75.0% of its last 8 reported quarters.

    Bear case

    • CCEL has a -6.3% net profit margin.

    CCEL Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    -161.8%
    EPS estimate (fiscal period ending Nov 30, 2026)
    $0.10

    CCEL Dividend

    Forward yield
    0.0%
    Payout ratio
    0.0%

    Frequently Asked Questions About CCEL

    Does CCEL pay dividends?

    CryoCell International Inc (CCEL) has a dividend payment track record. See the CCEL dividend history page for its current payment status, TTM yield, and recorded payments.

    What is CCEL's market cap?

    CryoCell International Inc (CCEL) has a market capitalization of $37.49M with a current stock price of $4.65.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In